Search company, investor...

Predict your next investment

Corporation
gensci-china.com

Investments

1

Portfolio Exits

1

Partners & Customers

1

About GeneScience Pharmaceuticals

GeneScience Pharmaceuticals is a biopharmaceutical producer. It is also a manufacturer of recombinant human growth hormone.

Headquarters Location

72 Tianhe Street Changchum High-Tech Dev. Zone

Changchun, Jilin,

China

+86 43185195060

Want to inform investors similar to GeneScience Pharmaceuticals about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest GeneScience Pharmaceuticals News

Human Growth Hormone (HGH) Market Focusing on Top Pharmaceutical Companies Pfizer, GeneScience Pharmaceuticals, Merck Serono, ovo Nordisk, Eli Lilly and Company

Dec 15, 2020

Search jobs 15-Dec-2020 Human Growth Hormone (HGH) Market Focusing on Top Pharmaceutical Companies Pfizer, GeneScience Pharmaceuticals, Merck Serono, ovo Nordisk, Eli Lilly and Company Pune, Maharashtra, India, December 15 2020 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:In 2019, the market size of Human Growth Hormone Drugs is 37000 million US$ and it will reach 66500 million US$ in 2025, growing at a CAGR of 7.6% from 2019. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Growth Hormone Drugs. HGH, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Produced synthetically, HGH is the active ingredient in a number of prescription drugs and in other products available widely over the Internet. Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism. Moreover, the usage of human growth hormone drugs in growth hormone deficient patient has shown significant positive results on the patient’s working capacity, mental alertness and memory. The over secretion of growth hormone leads to gigantism and its deficiency causes dwarfism. The human growth hormone drugs are developed and manufactured by recombinant DNA technology. Earlier, these drugs were mostly used as replacement therapy in pediatric and adult patients, having the deficiency of growth hormones. However, the technological advancements and increased research and development in growth hormone drugs, have resulted in the development of anti-aging drugs and performance enhancers. Get Sample Copy of The Human Growth Hormone Market Report 2020@ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=80671&RequestType=Sample                                                                                                                                                                                                                                                                                                *The sample pages of this report is immediately accessible on-demand. ** In global market, the following companies are covered: Eli Lilly and Company (US) Ferring Holding SA (Switzerland) Genentech, Inc. (US) GeneScience Pharmaceuticals Co., Ltd. (China) Merck KgaA (Germany) Novo Nordisk A/S (Denmark) Pfizer, Inc. (US) Sandoz International GmbH (Germany) This report studies the global market size of Human Growth Hormone Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). Market Segment by Product Type Norditropin Genotropin Humatrope Saizen Omnitrope Somatropin Biopartners Market Segment by Application Prader-Willi Syndrome Turner Syndrome Short Stature Homeobox Gene Small for Gestational Age Chronic Renal Insufficiency Short Bowel Syndrome This study presents the Human Growth Hormone Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019. Key Regions split in this report: breakdown data for each region. United States China European Union Rest of World (Japan, Korea, India and Southeast Asia) The study objectives are: To analyze and research the Human Growth Hormone Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast. To present the key Human Growth Hormone Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players. To split the breakdown data by regions, type, companies and applications To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends, drivers, influence factors in global and regions To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market Table of Contents     3.1 Human Growth Hormone Drugs Sales by Manufacturers         3.1.1 Human Growth Hormone Drugs Sales by Manufacturers 2014-2019         3.1.2 Human Growth Hormone Drugs Sales Market Share by Manufacturers 2014-2019     3.2 Revenue by Manufacturers         3.2.2 Human Growth Hormone Drugs Revenue Share by Manufacturers (2014-2019)         3.2.3 Global Human Growth Hormone Drugs Market Concentration Ratio (CR5 and HHI)     3.3 Human Growth Hormone Drugs Price by Manufacturers     3.4 Key Manufacturers Human Growth Hormone Drugs Plants/Factories Distribution and Area Served     3.5 Date of Key Manufacturers Enter into Human Growth Hormone Drugs Market     3.6 Key Manufacturers Human Growth Hormone Drugs Product Offered     3.7 Mergers & Acquisitions, Expansion Plans Continued…. About us: Brandessence Market Research and Consulting Pvt. Ltd. Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London. Contact us at: +44-2038074155 or mail us at  sales@brandessenceresearch.com

GeneScience Pharmaceuticals Investments

1 Investments

GeneScience Pharmaceuticals has made 1 investments. Their latest investment was in Rani Therapeutics as part of their Series D - II on February 2, 2018.

CBI Logo

GeneScience Pharmaceuticals Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/8/2018

Series D - II

Rani Therapeutics

$53M

Yes

8

Date

2/8/2018

Round

Series D - II

Company

Rani Therapeutics

Amount

$53M

New?

Yes

Co-Investors

Sources

8

GeneScience Pharmaceuticals Portfolio Exits

1 Portfolio Exit

GeneScience Pharmaceuticals has 1 portfolio exit. Their latest portfolio exit was Rani Therapeutics on July 30, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/30/2021

IPO

$99M

Public

16

Date

7/30/2021

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

16

GeneScience Pharmaceuticals Partners & Customers

1 Partners and customers

GeneScience Pharmaceuticals has 1 strategic partners and customers. GeneScience Pharmaceuticals recently partnered with Foresee Pharmaceuticals on November 11, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

11/17/2020

Licensor

Taiwan

Foresee Pharmaceuticals Enters Exclusive License Agreement With GenSci For The Commercialization Of Camcevi(TM) In China

We are highly confident in Camcevi ™ 's potential in the China market , and see this as the foundation to a potentially broader partnership with GenSci in the future , related to Foresee 's SIF technology and related programs . ''

2

Date

11/17/2020

Type

Licensor

Business Partner

Country

Taiwan

News Snippet

Foresee Pharmaceuticals Enters Exclusive License Agreement With GenSci For The Commercialization Of Camcevi(TM) In China

We are highly confident in Camcevi ™ 's potential in the China market , and see this as the foundation to a potentially broader partnership with GenSci in the future , related to Foresee 's SIF technology and related programs . ''

Sources

2

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.